"ACCULINK for Revascularization of Carotids in High Risk Patients The ARCHeR Trial"

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

581

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

October 31, 2003

Study Completion Date

November 30, 2003

Conditions
Carotid AtherosclerosisCarotid Artery Disease
Interventions
DEVICE

Over-the-wire & Rapid Exchange ACCULINK (tm) Carotid Stent & ACCUNET (tm) embolic protection system

"Two rapid exchange devices will be evaluated: the RX ACCUNET Embolic Protection System (RX ACCUNET) and the RX ACCULINK Carotid Stent System (RX ACCULINK).~The RX ACCUNET Embolic Protection System is intended to facilitate the placement of diagnostic and therapeutic devices during interventional procedures and to capture embolic material that may be present during carotid artery interventional procedures.~The RX ACCULINK™ Carotid Stent System is intended for the treatment of carotid artery stenosis in the internal carotid artery (ICA), with or without involvement of the contiguous common carotid artery (CCA), in asymptomatic patients and symptomatic patients."

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT00180518 - "ACCULINK for Revascularization of Carotids in High Risk Patients The ARCHeR Trial" | Biotech Hunter | Biotech Hunter